A galactose‐1‐phosphate uridylyltransferase‐null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue‐specific and longitudinal differences in galactose metabolism.

MLA

Rasmussen, Shauna A., et al. “A Galactose‐1‐phosphate Uridylyltransferase‐null Rat Model of Classic Galactosemia Mimics Relevant Patient Outcomes and Reveals Tissue‐specific and Longitudinal Differences in Galactose Metabolism.” Journal of Inherited Metabolic Disease, vol. 43, no. 3, May 2020, pp. 518–28. EBSCOhost, https://doi.org/10.1002/jimd.12205.

APA

Rasmussen, S. A., Daenzer, J. M. I., MacWilliams, J. A., Head, S. T., Williams, M. B., Geurts, A. M., Schroeder, J. P., Weinshenker, D., & Fridovich, K. J. L. (2020). A galactose‐1‐phosphate uridylyltransferase‐null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue‐specific and longitudinal differences in galactose metabolism. Journal of Inherited Metabolic Disease, 43(3), 518–528. https://doi.org/10.1002/jimd.12205

Chicago

Rasmussen, Shauna A., Jennifer M. I. Daenzer, Jessica A. MacWilliams, S. Taylor Head, Martine B. Williams, Aron M. Geurts, Jason P. Schroeder, David Weinshenker, and Keil, Judith L. Fridovich. 2020. “A Galactose‐1‐phosphate Uridylyltransferase‐null Rat Model of Classic Galactosemia Mimics Relevant Patient Outcomes and Reveals Tissue‐specific and Longitudinal Differences in Galactose Metabolism.” Journal of Inherited Metabolic Disease 43 (3): 518–28. doi:10.1002/jimd.12205.